- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07304895
Center M Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is a randomized control trial (RCT) with two parallel arms, 1) an intervention arm: Center M added to treatment as usual (TAU), defined as standard prenatal care, and 2) a control arm: TAU, again defined as standard prenatal care. As both groups will be obtaining services through the Center for Women's Health at OHSU, offered standard prenatal care is expected to be similar in both arms. The study will be masked to the PI, Co-I's, consultants, and anyone directly collecting or analyzing study data. Primary prenatal care providers will also be masked to subject assignment. Participant and interventionist masking is not possible due to the nature of the intervention arm. The research coordinator(s), research assistants needing to communicate with research participants about group activities (e.g., responding to logistical emails), and volunteers who support the research coordinator or research assistants with communications regarding groups will also be unmasked. Participants will be randomized by the research coordinator or designated research assistant after eligibility determination and study consent.
The Center M intervention proceeds sequentially with weekly one-hour group sessions led by a trained, masters-level (or equivalent) therapist. Each group will include 3-6 participants. These sessions are conducted digitally via WebEx. Center M session structure aligns with mindfulness based cognitive therapy by including: 1) introduction of a core theme and rationale for how this theme relates to mental well-being (i.e., psychoeducation); 2) teaching core mindfulness (including an emphasis on self-compassion) and CBT skills; 3) facilitating in-session practice of skills (i.e., experiential learning); and 4) reviewing home practice of skills as well as barriers to practice. Sessions are focused on skill development, both through active engagement in practice during group sessions and individual home practice. Center M content teaches skills that increase capability for effectively navigating general life stress and the unique stresses of pregnancy and parenting. It is further designed to increase awareness of early warning signs of perinatal depression to allow for identification of the need for additional resources (including more intensive preventive intervention). The curriculum is designed to be a 'light touch', or minimum necessary intervention that still retains the capacity to prevent perinatal depression. Examples and summaries of the curriculum and accompanying handouts and homework are outlined below and full curriculum, handouts, and homework are available in the IRB documents. The Center M curriculum, handouts and homework follows the parent model MBCT curriculum, with alterations made in direct communication with Sona Dimidjian, PhD, and Sherryl Goodman, PhD, the developers of the parent model. The Center M adaptation has been accomplished with the support and involvement of Drs. Dimidjian and Goodman.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Currently pregnant at ≥ 12 weeks of gestation age (GA)
- ≤ 34 weeks GA at time of Center M intervention initiation
- Receiving prenatal care through the Center for Women's Health at Oregon Health & Science University
- Able to fluently understand, speak and read English
- Available, able and willing to attend online group sessions
- Willing and able to receive home practice materials on an accessible smartphone, tablet or computer
- Residing in Oregon or Washington
- Willingness to participate in either randomization arm
Exclusion Criteria:
- Current or past enrollment in a formal mindfulness-based intervention group
- Score in the "severe" range on the Edinburgh Postnatal Depression Scale (EPDS) (≥ 20) or Patient History Questionnaire (PHQ-9) (≥ 20)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Center M
In addition to standard prenatal care, participants will participate in Center M sessions, which are weekly one-hour digital group sessions led by a therapist.
Each group will include 3-6 participants.
The Center M session structure aligns with mindfulness-based cognitive therapy by including mental well-being, core mindfulness and cognitive behavioral therapy skills, in-session practice of skills, and home practice skills.
Center M content teaches skills that increase capability for effectively navigating general life stress and the unique stresses of pregnancy and parenting.
|
In addition to standard prenatal care, participants will participate in Center M sessions, which are weekly one-hour digital group sessions led by a therapist.
Each group will include 3-6 participants.
The Center M session structure aligns with mindfulness-based cognitive therapy by including mental well-being, core mindfulness and cognitive behavioral therapy skills, in-session practice of skills, and home practice skills.
Center M content teaches skills that increase capability for effectively navigating general life stress and the unique stresses of pregnancy and parenting.
Other Names:
|
|
No Intervention: Treatment as Usual (TAU)
Those randomized to TAU will receive prenatal care as it is standardly delivered in their provider's clinical setting, including perinatal screenings and related educational handouts.
Participants will be able to engage in any services recommended by their primary prenatal provider or that they voluntarily initiate, including mental health treatment.
Participants will not be proscribed from engaging in other recommended interventions or care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in EPDS scores (baseline to 6 weeks)
Time Frame: Difference between baseline and 6 weeks postpartum
|
Measured by the Edinburgh Postnatal Depression Scale (EPDS).
EPDS is scored on a scale from 0 to 30 with higher scores representing more symptoms of depression.
|
Difference between baseline and 6 weeks postpartum
|
|
Change in PHQ scores (baseline to 6 weeks)
Time Frame: Difference between baseline and 6 weeks postpartum
|
Measured by the Patient Health Questionnaire (PHQ-9).
PHQ-9 is scored on a scale from 0 to 27 with higher scores representing more symptoms of depression.
|
Difference between baseline and 6 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in EPDS scores (baseline to 3 months)
Time Frame: Difference between baseline and 3 months postpartum
|
Measured by the Edinburgh Postnatal Depression Scale (EPDS).
EPDS is scored on a scale from 0 to 30 with higher scores representing more symptoms of depression.
|
Difference between baseline and 3 months postpartum
|
|
Change in PHQ scores (baseline to 3 months)
Time Frame: Difference between baseline and 3 months postpartum
|
Measured by the Patient Health Questionnaire (PHQ-9).
PHQ-9 is scored on a scale from 0 to 27 with higher scores representing more symptoms of depression.
|
Difference between baseline and 3 months postpartum
|
|
Change in Mindfulness
Time Frame: Compared between baseline and following the 4 week intervention, between 30 and 38 weeks of gestation.
|
Measured by the Five Facet Mindfulness Questionnaire (FFMQ).
Average total score can be between 1 and 5 with 5 representing the highest level of mindfulness.
|
Compared between baseline and following the 4 week intervention, between 30 and 38 weeks of gestation.
|
|
Change in Emotional Regulation
Time Frame: Compared between baseline and following the 4 week intervention, between 30 and 38 weeks of gestation.
|
Measured by the Emotional Regulation Questionnaire (ERQ).
It consists of two subscales, reappraisal and suppression.
For the reappraisal subscale, scores can be between 6 and 42 with higher scores representing a more positive outcome.
For the suppression subscale, scores can be between 4 and 28 with a higher score representing a worse outcome.
|
Compared between baseline and following the 4 week intervention, between 30 and 38 weeks of gestation.
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY00029027
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perinatal Depression
-
Beth Israel Deaconess Medical CenterNational Institute of Mental Health (NIMH)RecruitingTesting "Doula Link", a Multi-Component Intervention to Improve Perinatal Mental Health (Doula Link)Perinatal Depression | Perinatal AnxietyUnited States
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH)Not yet recruitingPerinatal Depression | Anxiety Sensitivity | Perinatal Anxiety
-
University of WashingtonCompleted
-
National Taiwan University HospitalNot yet recruitingPerinatal Depression | Perinatal Anxiety | Maternal Mental HealthTaiwan
-
University of SevilleHealth Service of Andalucia; Junta de AndaluciaNot yet recruitingPerinatal Depression | Perinatal Anxiety
-
University of SevilleJunta de Andalucia; Andalusian Health ServiceNot yet recruitingPerinatal Depression | Perinatal Anxiety
-
Sameera ShafiqCompletedPerinatal Depression | Perinatal AnxietyPakistan
-
Weill Medical College of Cornell UniversityRecruitingPerinatal Depression | Perinatal AnxietyUnited States
-
McMaster UniversityActive, not recruitingPerinatal Depression | FathersCanada
-
University of California, Los AngelesFoundation for Women's HealthNot yet recruitingDepression | Perinatal DepressionUnited States
Clinical Trials on Center M
-
Oregon Health and Science UniversityCompleted
-
Oregon Health and Science UniversityNational Institute of Mental Health (NIMH)Completed
-
Maternal and Child Health Hospital of FoshanRecruitingEmergency Cesarean SectionChina
-
Hospital Clinic of BarcelonaRecruitingUpper Limb Weakness Due to Central Neurologic Injury | Isquemic StrokeSpain
-
University of AarhusAarhus University HospitalCompleted
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma,DLBCLChina
-
Merck Sharp & Dohme LLCCompletedMeasles | Rubella | Mumps | VaricellaFrance, Italy
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationActivities of Daily Living | Social Isolation in Older Adults | Quality of Life (QOL)United States
-
Fundació Institut de Recerca de l'Hospital de la...Sheba Medical Center; iMinds; Semmelweis University; AQuAS, Agència de Qualitat...CompletedSchizophreniaSpain, Hungary, Israel
-
Samueli Institute for Information BiologyWilliam Beaumont Army Medical Center; Palmer Center for Chiropractic Research... and other collaboratorsUnknown